Product Information
VERAPAMIL ER 180 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.1930 per EA under NDC 75834015801. Its NADAC has been published 363 times since Jul 17, 2019.
Strength
180 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834015801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206173On Market Since
5/15/2019
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL ER 180 MG TABLET has been published 363 times since Jul 17, 2019, and over the history we have for it it has declined 4.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1930 per EA |
|---|---|
| All-time high | $0.2281 (Apr 15, 2020) |
| All-time low | $0.1572 (Nov 20, 2024) |
| 52-week high | $0.1940 |
| 52-week low | $0.1781 |
| Median price | $0.1931 |
| Average price | $0.1950 |
| Largest weekly change | -17.6% (Nov 20, 2024) |
| Weeks tracked | 363 |
| Tracking since | Jul 17, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VERAPAMIL ER 180 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL ER 180 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.1930 per EA (NDC 75834015801), effective Jun 24, 2026.
How has the price of VERAPAMIL ER 180 MG TABLET changed over time?
Over the history we have for it, the NADAC for VERAPAMIL ER 180 MG TABLET has declined 4.3%. It has been tracked across 363 weekly CMS publications since Jul 17, 2019.
What are the highest and lowest recorded NADAC prices for VERAPAMIL ER 180 MG TABLET?
Since Jul 17, 2019, the NADAC for VERAPAMIL ER 180 MG TABLET has ranged from a low of $0.1572 (Nov 20, 2024) to a high of $0.2281 (Apr 15, 2020), with a median of $0.1931 per EA.
Are there cheaper alternatives to VERAPAMIL ER 180 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as VERAPAMIL ER 180 MG TABLET, but none are currently priced below it.
Who manufactures VERAPAMIL ER 180 MG TABLET?
VERAPAMIL ER 180 MG TABLET (NDC 75834015801) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification